[HTML][HTML] Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies

M Elmowafy, MM Al-Sanea - Saudi Pharmaceutical Journal, 2021 - Elsevier
NLCs have provoked the incessant impulsion for the development of safe and valuable drug
delivery systems owing to their exceptional physicochemical and then biocompatible …

[HTML][HTML] The multifaceted role of curcumin in advanced nanocurcumin form in the treatment and management of chronic disorders

P Tagde, P Tagde, F Islam, S Tagde, M Shah… - Molecules, 2021 - mdpi.com
Curcumin is the primary polyphenol in turmeric's curcuminoid class. It has a wide range of
therapeutic applications, such as anti-inflammatory, antioxidant, antidiabetic …

Advances in nanoparticle and microparticle delivery systems for increasing the dispersibility, stability, and bioactivity of phytochemicals

DJ McClements - Biotechnology advances, 2020 - Elsevier
Application of bioactive phytochemicals in foods, supplements, and pharmaceuticals is often
limited because of their poor solubility, stability, and bioavailability. Phytochemical oral …

[HTML][HTML] Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration

VN Thuy, TV Van, AH Dao, BJ Lee - OpenNano, 2022 - Elsevier
Enteral administration is the most convenient route despite the gastrointestinal physiological
barriers. Nanostructured lipid carriers (NLCs) have emerged as a promising strategy for …

[HTML][HTML] Oxidative stress, inflammation, gut dysbiosis: what can polyphenols do in inflammatory bowel disease?

L Li, P Peng, N Ding, W Jia, C Huang, Y Tang - Antioxidants, 2023 - mdpi.com
Inflammatory bowel disease (IBD) is a long-term, progressive, and recurrent intestinal
inflammatory disorder. The pathogenic mechanisms of IBD are multifaceted and associated …

Advances in colon-targeted nano-drug delivery systems: challenges and solutions

M Naeem, UA Awan, F Subhan, J Cao… - Archives of pharmacal …, 2020 - Springer
Nano-drug delivery systems (NDDS) for colon-targeted drug delivery are an active area of
research on local diseases affecting the colon, such as ulcerative colitis, Crohn's disease …

[HTML][HTML] The role of tissue-resident macrophages in the development and treatment of inflammatory bowel disease

S Ma, J Zhang, H Liu, S Li, Q Wang - Frontiers in cell and …, 2022 - frontiersin.org
Inflammatory bowel disease (IBD), comprising Crohn's disease and ulcerative colitis, is a
refractory disease with many immune abnormalities and pathologies in the gastrointestinal …

Enhancing curcumin oral bioavailability through nanoformulations

VS Ipar, A Dsouza, PV Devarajan - European journal of drug metabolism …, 2019 - Springer
Curcumin is a promising therapeutic agent that exhibits manifold therapeutic activities.
However, it is challenging to study curcumin as it exhibits poor aqueous solubility and low …

[HTML][HTML] Curcumin and its modified formulations on inflammatory bowel disease (IBD): The story so far and future outlook

A Karthikeyan, KN Young, M Moniruzzaman… - Pharmaceutics, 2021 - mdpi.com
Inflammatory bowel disease (IBD) is a chronic relapsing and remitting inflammatory disorder
of the small intestine and colon. IBD includes ulcerative colitis (UC) and Crohn's disease …

[HTML][HTML] Research progress of natural product-based nanomaterials for the treatment of inflammation-related diseases

F Cao, SY Gui, X Gao, W Zhang, ZY Fu, LM Tao… - Materials & Design, 2022 - Elsevier
Inflammatory diseases present with dysregulated inflammatory reactions and oxidative
stress, resulting in heavy health-associated economic burden to society. Current mainstream …